ELAVL1 and metabolic dysfunction-associated steatotic liver disease: In summary, HuR functions as a pivotal post-transcriptional regulator of liver fibrosis, with cell-type–specific effects that may drive both the progression and resolution of fibrogenic responses in MASLD.